Table 2.
Clinical and demographic characteristics of adults newly added to the wait list for kidney transplantation (primary cohort)1
| Wait list, no transplant2 (n = 29214) | SCD2 kidney recipient (n = 7016) | CDC2 kidney recipient (n = 671) | ECD2 kidney recipient (n = 1936) | DCD2 kidney recipient (n = 794) | p-Value | |
|---|---|---|---|---|---|---|
| Mean age in yrs (s.e) | 50.6 (0.1) | 50.6 (0.2) | 50.8 (0.5) | 59.6 (0.2) | 50.8 (0.5) | <0.01 |
| Male gender (%) | 17 380 (59.5) | 4226 (60.2) | 431 (64.2) | 1206 (62.3) | 500 (63.0) | <0.01 |
| Race (%) | <0.01 | |||||
| White | 12 475 (42.7) | 3769 (53.7) | 341 (50.8) | 1039 (53.7) | 436 (54.9) | |
| Black | 9439 (32.3) | 1769 (25.2) | 175 (26.1) | 502 (25.9) | 255 (32.1) | |
| Hispanic | 4804 (16.4) | 1031 (14.7) | 93 (13.9) | 221 (11.4) | 52 (6.6) | |
| Asian | 1856 (6.4) | 319 (4.6) | 47 (7.0) | 145 (7.5) | 39 (4.9) | |
| Other | 640 (2.2) | 128 (1.8) | 15 (2.2) | 29 (1.5) | 12 (1.5) | |
| Dialysis (%) | 22 766 (77.9) | 5429 (77.4) | 479 (71.4) | 1518 (78.4) | 638 (80.4) | 0.01 |
| Hepatitis C seropositive (%)3 | N/A | 396 (5.7) | 48 (7.2) | 81 (4.2) | 33 (4.2) | <0.01 |
| Median days on the wait list | 889 | 419 | 383 | 453 | 545 | <0.01 |
| Diabetes | 13 063 (44.7) | 2453 (35.0) | 241 (35.9) | 872 (45.0) | 298 (37.5) | <0.01 |
| Median percent peak PRA | 2 | 0 | 0 | 0 | 0 | <0.01 |
| High PRA (%)4 | 8453 (28.9) | 1299 (18.5) | 121 (18.0) | 222 (11.5) | 121 (15.2) | <0.01 |
| Blood group (%) | <0.01 | |||||
| A | 8431 (28.9) | 2976 (42.4) | 246 (36.7) | 834 (43.1) | 382 (48.1) | |
| B | 4617 (15.8) | 783 (11.2) | 99 (14.8) | 200 (10.3) | 85 (10.7) | |
| AB | 808 (2.8) | 538 (7.7) | 41 (6.1) | 119 (6.2) | 55 (6.9) | |
| O | 15 358 (52.6) | 2719 (38.8) | 285 (42.5) | 783 (40.4) | 272 (34.3) |
Wait list: These individuals were added to the wait list but did not receive a transplant by the end of follow-up; SCD = standard criteria donor; CDC = Centers for Disease Control designation of donor as increased risk for viral infection; ECD = extended criteria donor; DCD = donation after cardiac death.
Recipients of kidneys from live donors, recipients of kidneys from deceased donors seropositive for hepatitis C and recipients of kidneys from deceased donors that met criteria for ECD-DCD, ECD-CDC, DCD-CDC or ECD-DCD-CDC were not included in the table; these recipients were censored at the time of transplantation.
OPTN does not collect data on hepatitis C status of individuals on the wait list.
Defined as peak PRA >20%.